Lyfegen Introduces AI Contracting Companion for Pharmaceutical Market Access

March 05, 2026
Lyfegen has launched its AI Contracting Companion, designed to help pharmaceutical organizations manage complex global pricing and contracting decisions through an integrated, AI-supported framework.

Lyfegen has launched its AI Contracting Companion, a generative AI tool designed to streamline drug pricing and contracting processes across global and local market access teams, announced in a press release.

The AI Contracting Companion creates a unified environment for pharmaceutical organizations to make structured, scalable contracting decisions. It integrates clinical evidence, pricing constraints, and payer behavior into a single framework to generate contracting strategies, rebate scenarios, and comparative evaluations.

The system provides transparent, repeatable outputs to support teams working with complex multi-market scenarios. It is built to improve decision-making speed while maintaining compliance and control through shared logic and traceable methodologies.

Unveiled at the World Evidence, Pricing and Access Congress in Amsterdam, the AI Contracting Companion is now available as part of the Lyfegen Platform.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

03/05
DentScribe Receives USPTO Notice of Allowance for AI Dentistry Patent
03/05
Senhwa Biosciences Signs AI-Driven Drug Development Partnership with CellType
03/05
Procode AI Launches with $4 Million and Acquires The Auctus Group
03/05
Droplet Biosciences Cuts Cancer Genomic Analysis Time with NVIDIA GPUs
03/04
Ease Health Raises $41 Million to Build AI-Native Platform for Behavioral Health

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like